CTSI’s Catalyst Awards Program Marks First Industry Partnership

By John Daigre on February 12, 2014

The Clinical and Translational Science Institute at UCSF has entered into a three-year collaboration with MedImmune, the global biologics research and development arm of AstraZeneca, marking its first industry partnership for CTSI’s Catalyst Awards program’s therapeutic track.